This article discusses the high potential of the RTS,S vaccine for malaria in children. Additionally, results show that not only will the vaccine likely lead to positive health outcomes, but it is expected to do so in a cost-effective manner.
This study analyzed the correlation between in-patient care and malaria mortality. Results found that the severity of in-patient cases varied markedly by country, and may suggest strategies to improve efficacy of in-patient care for malaria.
Adding RTS,S to existing control programs, assuming continuation of current levels of malaria exposure and of health system performance, will potentially avert 100–580 malaria deaths and 45,000 to 80,000 clinical episodes per 100,000 fully vaccinated children over an initial 10-year phase.